Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Бібліографічні деталі
Автор:	Hoque, Ismoth Ara
Інші автори:	Azam, Faruque
Формат:	Дисертація
Мова:	English
Опубліковано:	Brac University 2024
Предмети:	Lung cancer PFS ORR NSCLC subtypes Lungs > Cancer Clinical trials > Statistical methods
Онлайн доступ:	http://hdl.handle.net/10361/23164

Схожі ресурси

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
за авторством: Paul, Pulock
Опубліковано: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
за авторством: Rahman, Tasnim
Опубліковано: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
за авторством: Karim, Samia Binte
Опубліковано: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
за авторством: Flora, Sanzida Alam
Опубліковано: (2024)

Molecules associated with the development of lung cancer
за авторством: Rahman, Adree, та інші
Опубліковано: (2023)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
за авторством: Das, Reshita
Опубліковано: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
за авторством: Jeba, Joynob
Опубліковано: (2017)

A review on targeted therapies for lung cancer
за авторством: Ashraf, Anushey
Опубліковано: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
за авторством: Razna, Amrin Islam
Опубліковано: (2019)

Potential of liposomes for the treatment of lung cancer- a review
за авторством: Mim, Shanzida
Опубліковано: (2023)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
за авторством: Tania, Umme
Опубліковано: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
за авторством: Zangmo, Thinley
Опубліковано: (2024)

A review on recent advances in drugs for lung cancer treatment
за авторством: Noor, Fouzia
Опубліковано: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
за авторством: Pial, Sazia Afrin
Опубліковано: (2018)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
за авторством: Shabnam, Musharrat
Опубліковано: (2018)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
за авторством: Bristy, Israt Zerin
Опубліковано: (2021)

Immunotherapy in the Management of Lung Cancer
за авторством: Tasnim, Humayra
Опубліковано: (2022)

Lung cancer detection and classification using machine learning
за авторством: Arefin, Mahbubul, та інші
Опубліковано: (2023)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
за авторством: Mukti, Roushney Fatima, та інші
Опубліковано: (2016)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
за авторством: Nandy, Aditi
Опубліковано: (2022)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
за авторством: Shobnam, Sohana
Опубліковано: (2024)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
за авторством: Hasan, Sakib
Опубліковано: (2024)

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
за авторством: Monayem, Kazi Fahim
Опубліковано: (2024)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
за авторством: Oishy, Jannatun Noor
Опубліковано: (2024)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
за авторством: F. S. Amaral, André, та інші
Опубліковано: (2017)

A comparative study of lung cancer prediction using deep learning
за авторством: Mugdho, Aka Mohammad, та інші
Опубліковано: (2023)

Semantic segmentation with attention dense U-net for lung extraction from X-ray images
за авторством: Auvy, Akib Al Mahmud, та інші
Опубліковано: (2023)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
за авторством: Hossain, Safa Binte
Опубліковано: (2019)

Deep 3D convolutional neural network in early detection of Lung cancer
за авторством: Hossain, Khandoker Jobayer, та інші
Опубліковано: (2019)

Statistics and informatics in molecular cancer research

Smart biomedical device to predict lung diseases, COVID-19 and diabetes by using machine learning algorithms
за авторством: Hossain, Ashraful, та інші
Опубліковано: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
за авторством: Hasan, Amit
Опубліковано: (2024)

Machine learning as an indicator for breast cancer prediction
за авторством: Shadman, Tahsin Mohammed, та інші
Опубліковано: (2019)

The uses of bacteria in cancer therapy
за авторством: Saha, Shimul, та інші
Опубліковано: (2021)

Safety and efficacy of cisplatin combinations with vinorelbine, paclitaxel and gemcitabine – a systematic review and meta-analysis
за авторством: Islam, Inaya
Опубліковано: (2024)

Cancer risk factors: a critical review
за авторством: Tabassum, Tahsina
Опубліковано: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
за авторством: Nawar, Anika
Опубліковано: (2019)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
за авторством: Abir, Shifaty Nur
Опубліковано: (2024)

Targeting BRAFV600E in the treatment of CRC
за авторством: Roja, Mashwiyat Samrin
Опубліковано: (2024)

The impact of cell penetrating peptides in prospective cancer therapy: a review
за авторством: Nashrah, Zannatul
Опубліковано: (2023)